Drug-resistant tuberculosis: A disease of target populations in Houston, Texas

Journal of Infection - Tập 53 Số 1 - Trang 5-11 - 2006
Hana M. El Sahly1,2, Larry D. Teeter3, R. Pawlak3, James M. Musser3, Edward A. Graviss1,3
1Department of Medicine, Center for Human Bacterial Pathogenesis Research, Baylor College of Medicine, Houston, TX, USA
2Department of Molecular Virology and Microbiology, Center for Human Bacterial Pathogenesis Research, Baylor College of Medicine, Houston, TX, USA
3Department of Pathology, Center for Human Bacterial Pathogenesis Research, Baylor College of Medicine, Houston, TX, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Crofton, 1948, Streptomycin resistance in pulmonary tuberculosis, Br Med J, 2, 1009, 10.1136/bmj.2.4588.1009

Goble, 1993, Ackerson L, Horsburgh CR Jr. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin, N Engl J Med, 328, 527, 10.1056/NEJM199302253280802

Geerligs, 2000, Van Soolingen D, van Der Werf TS. Multidrug-resistant tuberculosis: long-term treatment outcomes in The Netherlands, Int J Tuberc Lung Dis, 4, 758

Moore-Gillon, 2001, Multidrug-resistant tuberculosis: this is the cost, Ann NY Acad Sci, 953, 233, 10.1111/j.1749-6632.2001.tb11382.x

2003, Treatment of tuberculosis, Am J Respir Crit Care Med, 167, 603, 10.1164/rccm.167.4.603

Park, 1996, Cohen H, Rom WN. Outcome of MDR-TB patients, 1983–1993: prolonged survival with appropriate therapy, Am J Respir Crit Care Med, 153, 317, 10.1164/ajrccm.153.1.8542137

Espinal, 2000, Kam KM, Khomenko AG, Migliori GB, et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries, JAMA, 283, 2537, 10.1001/jama.283.19.2537

Lan, 2001, A case series: initial outcome of persons with multidrug-resistant tuberculosis after treatment with the WHO standard retreatment regimen in Ho Chi Minh City, Vietnam, Int J Tuberc Lung Dis, 5, 575

2000, Anti-tuberculosis drug resistance in the world: prevalence and trends

2003

2002, Tuberculosis morbidity among United States-born and foreign-born populations—United States, 2000, Morb Mortal Wkly Rep, 5, 101

El Sahly, 2001, Teeter L, Musser JM, Graviss EA. Epidemiologic differences between United States- and foreign-born tuberculosis patients in Houston, Texas, J Infect Dis, 183, 461, 10.1086/318079

Talbot, 2000, Tuberculosis among foreign-born persons in the United States, 1993–1998, JAMA, 284, 2894, 10.1001/jama.284.22.2894

Espinal, 2001, Fusheng Z, Kim SJ, Tlali RE, et al. Determinants of drug-resistant tuberculosis: analysis of 11 countries, Int J Tuberc Lung Dis, 5, 887

Gordin, 1996, Cohn DL, Ernst J, Benator D, et al. The impact of human immunodeficiency virus infection on drug resistant tuberculosis, Am J Respir Crit Care, 154, 1478, 10.1164/ajrccm.154.5.8912768

Kenyon, 1999, Rumisha D, Binkin N, Maganu E. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana, Int J Tuberc Lung Dis, 3, 4

Dupon, 1995, Sentilhes A, Pellegrin JL, Morlat P, et al. Tuberculosis and HIV infection a cohort study of incidence and susceptibility to antituberculosis drugs, Bordeaux, 1985–1993. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine, AIDS, 9, 577, 10.1097/00002030-199506000-00008

Frieden, 1993, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City, N Engl J Med, 328, 521, 10.1056/NEJM199302253280801

Frieden, 1995, Tuberculosis in New York City: turning the tide, N Engl J Med, 333, 229, 10.1056/NEJM199507273330406

Fujiwara, 1997, Crawford JT, Glickman SE, Kreiswirth BN, et al. A continuing survey of drug-resistant tuberculosis, New York City, April 1994, Arch Int Med, 157, 531, 10.1001/archinte.157.5.531

Agerton, 1997, Pozsik C, Plikaytis B, Woodley C, et al. Transmission of a highly drug resistant strain (strain W1) of Mycobacterium tuberculosis. Community outbreak and nosocomial transmission via a contaminated bronchoscope, JAMA, 278, 1073, 10.1001/jama.278.13.1073

Conover, 2001, Schoenstadt L, McAuley J, Onorato I, et al. Outbreak of multidrug-resistant tuberculosis at a methadone-treatment program, Int J Tuberc Lung Dis, 5, 59

Nivin, 1998, Frieden TR, Fujiwara PI. A continuing outbreak of multidrug-resistant tuberculosis with nosocomial transmission in a hospital nursery, Clin Infect Dis, 26, 303, 10.1086/516296

Ridzon, 1997, Weismuller P, Maxwell R, Elcock M, et al. Outbreak of drug-resistant tuberculosis with a second-generation transmission in a high school in California, J Pediatr, 131, 863, 10.1016/S0022-3476(97)70034-9

Sreevastan, 1997, Connell ND, Kreiswirth BN, Whittam TS, et al. Restricted structural gene polymorphism in the M. tuberculosis complex indicates evolutionarily recent global dissemination, Proc Natl Acad Sci USA, 94, 9869, 10.1073/pnas.94.18.9869

van Embden, 1993, Dale JW, Eisenach KD, Gicquel B, et al. Strain identification of M. tuberculosis by DNA fingerprinting: recommendations for a standard methodology, J Clin Microbiol, 31, 406, 10.1128/JCM.31.2.406-409.1993

Kamerbeek, 1997, van Agterveld M, van Soolingen D, Kuijper S, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology, J Clin Microbiol, 35, 907, 10.1128/JCM.35.4.907-914.1997

Pablos-Mendez, 1998, Binkin N, Rieder HL, Bustreo F, et al. Global surveillance of antituberculosis-drug resistance, 1994–1997, N Engl J Med, 338, 1641, 10.1056/NEJM199806043382301

Agerton, 1999, Shilkret KL, Reves R, Schluter WW, et al. Spread of a strain W, a highly drug resistant strain of Mycobacterium tuberculosis, across the United States, Clin Infect Dis, 29, 85, 10.1086/520187

Moss, 1997, Hewlett D Jr, Sharp V, Chiliade P, et al. A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York, Int J Tuberc Lung Dis, 1, 115

Weis, 1994, King B, Nunn M, Matney GB, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis, N Engl J Med, 330, 1179, 10.1056/NEJM199404283301702

Munsiff, 2002, Li J, Sharma A, Bifani P, et al. Molecular epidemiology of multidrug-resistant tuberculosis, New York City, 1995–1997, Emerg Infect Dis, 8, 1230, 10.3201/eid0811.020288

Yaganehdoost, 1999, Adams GJ, Ramaswamy S, Wanger A, et al. Complex transmission dynamics of clonally related virulent Mycobacterium tuberculosis associated with barhopping by predominantly human immunodeficiency virus-positive gay men, J Infect Dis, 180, 1245, 10.1086/314991

El Sahly, 2004, Bui TT, Williams-Bouyer N, Escalante P, et al. Recurrent tuberculosis in Houston, Texas: a population-based study, Int J Tuberc Lung Dis, 8, 333

Antoniskis, 1990, Pleuritis as a manifestation of reactivation tuberculosis, Am J Med, 89, 447, 10.1016/0002-9343(90)90374-M

Elliot, 1995, Failure of drug penetration and acquisition of drug resistance in chronic tuberculous empyema, Tuberc Lung Dis, 76, 463, 10.1016/0962-8479(95)90016-0

Dutt, 1992, Tuberculous pleural effusion: 6-month-therapy with isoniazid and rifampin, Am Rev Respir Dis, 145, 1429, 10.1164/ajrccm/145.6.1429

Bamn, 1974, Rifampicin in plasma and pleural fluid after single oral doses, Eur J Clin Pharmacol, 7, 51, 10.1007/BF00614390

2002, Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculsosis with intermittent rifamycin-based regimens, Morb Mortal Wkly Rep, 51, 214